Sørensen PS - Search Results

1

Differential microRNA expression in blood in multiple sclerosis.

Søndergaard HB, Hesse D, Krakauer M, Sørensen PS, Sellebjerg F. Søndergaard HB, et al. Among authors: sorensen ps. Mult Scler. 2013 Dec;19(14):1849-57. doi: 10.1177/1352458513490542. Epub 2013 Jun 17. Mult Scler. 2013. PMID: 23773985

2

The role of intravenous immunoglobulin in the treatment of multiple sclerosis.

Sorensen PS. Sorensen PS. J Neurol Sci. 2003 Feb 15;206(2):123-30. doi: 10.1016/s0022-510x(02)00343-x. J Neurol Sci. 2003. PMID: 12559498 Review.

3

Clinical importance of neutralising antibodies against interferon beta in patients with relapsing-remitting multiple sclerosis.

Sorensen PS, Ross C, Clemmesen KM, Bendtzen K, Frederiksen JL, Jensen K, Kristensen O, Petersen T, Rasmussen S, Ravnborg M, Stenager E, Koch-Henriksen N; Danish Multiple Sclerosis Study Group. Sorensen PS, et al. Lancet. 2003 Oct 11;362(9391):1184-91. doi: 10.1016/S0140-6736(03)14541-2. Lancet. 2003. PMID: 14568740 Clinical Trial.

4

Significantly increased fractions of transformed to total alpha2-macroglobulin concentrations in plasma from patients with multiple sclerosis.

Jensen PE, Humle Jørgensen S, Datta P, Sørensen PS. Jensen PE, et al. Among authors: sorensen ps. Biochim Biophys Acta. 2004 Nov 5;1690(3):203-7. doi: 10.1016/j.bbadis.2004.06.010. Biochim Biophys Acta. 2004. PMID: 15511627 Free article.

5

IV immunoglobulins as add-on treatment to methylprednisolone for acute relapses in MS.

Sorensen PS, Haas J, Sellebjerg F, Olsson T, Ravnborg M; TARIMS Study Group. Sorensen PS, et al. Neurology. 2004 Dec 14;63(11):2028-33. doi: 10.1212/01.wnl.0000145798.61383.39. Neurology. 2004. PMID: 15596745 Clinical Trial.

6

Responsiveness of the Multiple Sclerosis Impairment Scale in comparison with the Expanded Disability Status Scale.

Ravnborg M, Blinkenberg M, Sellebjerg F, Ballegaard M, Larsen SH, Sørensen PS. Ravnborg M, et al. Among authors: sorensen ps. Mult Scler. 2005 Feb;11(1):81-4. doi: 10.1191/1352458505ms1120oa. Mult Scler. 2005. PMID: 15732271

7

CD26 + CD4 + T cell counts and attack risk in interferon-treated multiple sclerosis.

Sellebjerg F, Ross C, Koch-Henriksen N, Sørensen PS, Frederiksen JL, Bendtzen K, Sørensen TL. Sellebjerg F, et al. Among authors: sorensen ps, sorensen tl. Mult Scler. 2005 Dec;11(6):641-5. doi: 10.1191/1352458505ms1217oa. Mult Scler. 2005. PMID: 16320722 Clinical Trial.

8

Correlation of global N-acetyl aspartate with cognitive impairment in multiple sclerosis.

Mathiesen HK, Jonsson A, Tscherning T, Hanson LG, Andresen J, Blinkenberg M, Paulson OB, Sorensen PS. Mathiesen HK, et al. Among authors: sorensen ps. Arch Neurol. 2006 Apr;63(4):533-6. doi: 10.1001/archneur.63.4.533. Arch Neurol. 2006. PMID: 16606765

9

Persistence of neutralizing antibodies after discontinuation of IFNbeta therapy in patients with relapsing-remitting multiple sclerosis.

Petersen B, Bendtzen K, Koch-Henriksen N, Ravnborg M, Ross C, Sorensen PS; Danish Multiple Sclerosis Group. Petersen B, et al. Among authors: sorensen ps. Mult Scler. 2006 Jun;12(3):247-52. doi: 10.1191/135248505ms1324oa. Mult Scler. 2006. PMID: 16764336

10

[Treatment of multiple sclerosis--now and in future. The Danish Multiple Sclerosis Society and the Danish Multiple Sclerosis Group].

Sellebjerg FT, Sørensen PS; Dansk Selskab for Forskning i Multipel Sclerose og Dansk Multipel Sclerose Gruppe. Sellebjerg FT, et al. Among authors: sorensen ps. Ugeskr Laeger. 2007 Mar 19;169(12):1121. Ugeskr Laeger. 2007. PMID: 17394832 Danish. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

394 results

Search Page

Filters